JP2007531766A5 - - Google Patents

Download PDF

Info

Publication number
JP2007531766A5
JP2007531766A5 JP2007506547A JP2007506547A JP2007531766A5 JP 2007531766 A5 JP2007531766 A5 JP 2007531766A5 JP 2007506547 A JP2007506547 A JP 2007506547A JP 2007506547 A JP2007506547 A JP 2007506547A JP 2007531766 A5 JP2007531766 A5 JP 2007531766A5
Authority
JP
Japan
Prior art keywords
alkyl
hydrogen
formula
cyclohexane
independently selected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007506547A
Other languages
English (en)
Japanese (ja)
Other versions
JP4954864B2 (ja
JP2007531766A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/010878 external-priority patent/WO2005113011A2/en
Publication of JP2007531766A publication Critical patent/JP2007531766A/ja
Publication of JP2007531766A5 publication Critical patent/JP2007531766A5/ja
Application granted granted Critical
Publication of JP4954864B2 publication Critical patent/JP4954864B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007506547A 2004-04-01 2005-03-31 イオンチャネル調節化合物のプロドラッグおよびその使用 Expired - Fee Related JP4954864B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US55940504P 2004-04-01 2004-04-01
US60/559,405 2004-04-01
US58699204P 2004-07-08 2004-07-08
US60/586,992 2004-07-08
PCT/US2005/010878 WO2005113011A2 (en) 2004-04-01 2005-03-31 Prodrugs of ion channel modulating compounds and uses thereof

Publications (3)

Publication Number Publication Date
JP2007531766A JP2007531766A (ja) 2007-11-08
JP2007531766A5 true JP2007531766A5 (cg-RX-API-DMAC7.html) 2008-04-24
JP4954864B2 JP4954864B2 (ja) 2012-06-20

Family

ID=34972985

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2007506547A Expired - Fee Related JP4954864B2 (ja) 2004-04-01 2005-03-31 イオンチャネル調節化合物のプロドラッグおよびその使用
JP2007506319A Expired - Fee Related JP4991037B2 (ja) 2004-04-01 2005-03-31 イオンチャネル調節化合物を含む薬物結合体
JP2008088707A Pending JP2008179653A (ja) 2004-04-01 2008-03-28 Peg化イオンチャネル調節化合物
JP2008088708A Pending JP2008214353A (ja) 2004-04-01 2008-03-28 Peg化イオンチャネル調節化合物

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2007506319A Expired - Fee Related JP4991037B2 (ja) 2004-04-01 2005-03-31 イオンチャネル調節化合物を含む薬物結合体
JP2008088707A Pending JP2008179653A (ja) 2004-04-01 2008-03-28 Peg化イオンチャネル調節化合物
JP2008088708A Pending JP2008214353A (ja) 2004-04-01 2008-03-28 Peg化イオンチャネル調節化合物

Country Status (6)

Country Link
US (2) US7786119B2 (cg-RX-API-DMAC7.html)
EP (1) EP1729814A2 (cg-RX-API-DMAC7.html)
JP (4) JP4954864B2 (cg-RX-API-DMAC7.html)
CA (1) CA2561733A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA06011420A (cg-RX-API-DMAC7.html)
WO (1) WO2005094897A2 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090041841A1 (en) * 2003-05-02 2009-02-12 Cardiome Pharma Corp. Controlled release tablet formulations for the prevention of arrhythmias
US7705036B2 (en) * 2004-04-01 2010-04-27 Cardiome Pharma Corp. Deuterated aminocyclohexyl ether compounds and processes for preparing same
CA2561733A1 (en) * 2004-04-01 2005-10-13 Cardiome Pharma Corp. Pegylated ion channel modulating compounds
CA2561819A1 (en) 2004-04-01 2005-12-01 Cardiome Pharma Corp. Prodrugs of ion channel modulating compounds and uses thereof
WO2005097087A2 (en) * 2004-04-01 2005-10-20 Cardiome Pharma Corp. Merged ion channel modulating compounds and uses thereof
US8692002B2 (en) * 2004-11-18 2014-04-08 Cardiome Pharma Corp. Synthetic process for aminocyclohexyl ether compounds
JP5159616B2 (ja) 2005-06-15 2013-03-06 カーディオム ファーマ コーポレイション アミノシクロヘキシルエーテル化合物の調製のための合成プロセス
JP5004073B2 (ja) * 2006-06-13 2012-08-22 東レ・ファインケミカル株式会社 光学活性ベンジルオキシピロリジン誘導体塩酸塩粉体及びその製造法
EP1950198B1 (en) 2005-10-31 2014-08-06 Toray Fine Chemicals Co., Ltd. Process for production of benzyloxypyrrolidine derivative, and process for production of hydrochloride salt powder of optically active benzyloxypyrrolidine derivative
JP2007131597A (ja) * 2005-11-11 2007-05-31 Toray Fine Chemicals Co Ltd ベンジルオキシピロリジン誘導体の製造方法
JP5004067B2 (ja) * 2005-10-31 2012-08-22 東レ・ファインケミカル株式会社 ベンジルオキシ含窒素環状化合物の製造法
WO2008112287A1 (en) 2007-03-12 2008-09-18 Nektar Therapeutics Oligomer-beta blocker conjugates
US8748648B2 (en) 2007-09-06 2014-06-10 Nektar Therapeutics Oligomer-calcium channel blocker conjugates
WO2009089053A1 (en) * 2008-01-11 2009-07-16 Nektar Therapeutics Al, Corporation Oligomer-guanidine class conjugates
BRPI0919920A2 (pt) * 2008-10-22 2016-02-16 Acucela Inc compostos para tratamento de doenças e desordens oftálmicas
JP2012522782A (ja) * 2009-04-03 2012-09-27 ザ・ユニバーシティ・オブ・トレド 医薬のためのプラットフォームとしての、少なくとも1つの保護されたチオール領域を有するpeg−アルブミン組成物
US8993614B2 (en) 2012-03-15 2015-03-31 F. Hoffmann-La Roche Ag Substituted pyrrolidine-2-carboxamides
US9974759B2 (en) 2013-05-31 2018-05-22 Indiana University Research And Technology Corporation Beta 2 adrenoceptor antagonists for treating orthostatic hypotension

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684728A (en) 1979-01-12 1987-08-04 Bayer Aktiengesellschaft Solubilizing biologically active compounds with reactive hydrogen atoms
IT1145362B (it) * 1980-03-06 1986-11-05 Sigma Tau Ind Farmaceuti Classe di acil-derivati della carnitina procedimento per la loro preparazione e loro uso terapeutico
US5160734A (en) * 1987-11-25 1992-11-03 American Cyanamid Company Sustained release delivery system for substituted dihydropyridine calcium channel blockers
DE3871343D1 (de) * 1987-11-25 1992-06-25 American Cyanamid Co System fuer die verzoegerte (kontrollierte) freisetzung von substituierten dihydropyridin-calciumantagonisten.
US6517824B1 (en) * 1990-05-14 2003-02-11 University Of Medicine & Denistry Of New Jersey Polymer compositions comprising antifibrotic agents, and methods of treatment, pharmaceutical compositions, and methods of preparation therefor
US20030186869A1 (en) * 1990-05-14 2003-10-02 George Poiani Polymer compositions comprising antifibrotic agents, and methods of treatment, pharmaceutical compositions, and methods of preparation therefor
US5219564A (en) * 1990-07-06 1993-06-15 Enzon, Inc. Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon
US5244889A (en) 1991-11-26 1993-09-14 Ciba-Geigy Corporation Certain macrocyclic lactam derivatives
US6217869B1 (en) * 1992-06-09 2001-04-17 Neorx Corporation Pretargeting methods and compounds
US5298492A (en) 1992-08-04 1994-03-29 Schering Corporation Diamino acid derivatives as antihypertensives
US5681811A (en) * 1993-05-10 1997-10-28 Protein Delivery, Inc. Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same
US6191105B1 (en) * 1993-05-10 2001-02-20 Protein Delivery, Inc. Hydrophilic and lipophilic balanced microemulsion formulations of free-form and/or conjugation-stabilized therapeutic agents such as insulin
JP3563738B2 (ja) 1993-06-11 2004-09-08 エーザイ株式会社 アミノ酸誘導体
DE69429524T2 (de) * 1993-09-24 2002-08-08 The University Of British Columbia, Vancouver Aminocyclohexylester und ihre anwendung
KR100477070B1 (ko) * 1994-03-25 2006-04-21 이소테크니카 인코포레이티드 중수소화작용에의한의약품의효능강화법
US6441025B2 (en) * 1996-03-12 2002-08-27 Pg-Txl Company, L.P. Water soluble paclitaxel derivatives
PL189698B1 (pl) * 1996-03-12 2005-09-30 Pg Txl Co Kompozycja farmaceutyczna zawierająca lek przeciwnowotworowy i jej zastosowania
US6214966B1 (en) * 1996-09-26 2001-04-10 Shearwater Corporation Soluble, degradable poly(ethylene glycol) derivatives for controllable release of bound molecules into solution
WO1998019682A1 (en) 1996-11-01 1998-05-14 Magainin Pharmaceuticals Inc. Certain aminosterol compounds and uses therefor
EP0884325A1 (en) 1997-04-24 1998-12-16 Akzo Nobel N.V. Thrombin inhibitors containing a peptidyl heterocycle
US6342507B1 (en) * 1997-09-05 2002-01-29 Isotechnika, Inc. Deuterated rapamycin compounds, method and uses thereof
DE69832984T2 (de) * 1997-10-08 2006-09-21 Isotechnika, Inc., Edmonton DEUTERIERtE und undeuterierte CYCLOSPORIN-ANALOGA UND IHRE VERWENDUNG ALS IMMUNMODULIERENDE AGENtIEN
CN1217918C (zh) * 1998-04-01 2005-09-07 卡迪欧梅制药公司 氨基环己基醚化合物和其用途
EP1085890A1 (en) * 1998-06-08 2001-03-28 Advanced Medicine, Inc. Novel sodium channel drugs and uses
US6264975B1 (en) * 1998-10-20 2001-07-24 The University Of North Carolina At Chapel Hill Methods of hydrating mucosal surfaces
WO2000047547A2 (en) 1999-02-12 2000-08-17 Nortran Pharmaceuticals Inc. Cycloalkyl amine compounds and uses thereof
CA2372073A1 (en) 1999-04-29 2000-11-09 Merck Patent Gesellschaft Mit Beschraenkter Haftung Glycine cleavage system inhibitors as potential antipsychotics
CA2311483A1 (en) * 2000-06-12 2001-12-12 Gregory N Beatch IMIDAZO [1,2-A] PYRIDINIC ETHERS AND USES THEREOF
WO2002028412A1 (en) 2000-10-05 2002-04-11 Zealand Pharmaceuticals A/S Novel use of peptide
MXPA03002601A (es) * 2000-09-26 2005-02-25 Univ Arizona Foundation Compuestos y metodos de uso de los mismos en el tratamiento del cancer o de infecciones virales.
JP2002105067A (ja) 2000-09-28 2002-04-10 Teijin Ltd 2−フェニルチアゾール誘導体、およびそれを有効成分とする医薬組成物
US7524879B2 (en) * 2000-10-06 2009-04-28 Cardiome Pharma Corp. Ion channel modulating compounds and uses thereof
US7057053B2 (en) * 2000-10-06 2006-06-06 Cardiome Pharma Corp. Ion channel modulating compounds and uses thereof
WO2003004347A2 (en) * 2001-07-02 2003-01-16 Fmc Technologies, Inc. Riser pull-in method and apparatus
US6623729B2 (en) * 2001-07-09 2003-09-23 Korea Advanced Institute Of Science And Technology Process for preparing sustained release micelle employing conjugate of anticancer drug and biodegradable polymer
EP1411987A2 (en) * 2001-07-31 2004-04-28 Immunomedics, Inc. Targeted polymeric delivery systems
JP2003113084A (ja) 2001-10-02 2003-04-18 Mitsubishi Pharma Corp 肺高血圧症の治療及び/または予防薬
IL147953A (en) 2002-02-01 2008-04-13 Meir Bialer Derivatives and pharmaceutical compositions of n-hydroxymethyl tetramethylcyclopropyl-
AU2003232941A1 (en) 2002-06-07 2003-12-22 Glaxo Group Limited N-mercaptoacyl phenyalanine derivatives, process for their preparation, and pharmaceutical compositions containing them
ES2297216T3 (es) * 2002-06-21 2008-05-01 Suven Life Sciences Limited Indoles tetraciclicos arilsulfonil que tienen afinidad con el receptor de la serotonina.
KR20050035194A (ko) * 2002-06-28 2005-04-15 이데닉스 (케이만) 리미티드 플라비비리다에 감염 치료용 2'-c-메틸-3'-o-l-발린에스테르 리보푸라노실 사이티딘
WO2004014973A2 (en) * 2002-08-13 2004-02-19 Sirus Pharmaceuticals Ltd Biodegradable polymer
WO2004082585A2 (en) * 2003-03-20 2004-09-30 Sirus Pharmaceuticals Ltd Water-soluble conjugates of phenytoin
CA2524034A1 (en) * 2003-05-02 2004-11-18 Cardiome Pharma Corp. Uses of ion channel modulating compounds
DE60305200T2 (de) * 2003-05-02 2007-05-10 Cardiome Pharma Corp. Aminocyclohexylether-verbindungen und deren verwendung
KR100495009B1 (ko) * 2003-07-02 2005-06-14 삼성전자주식회사 화상형성 장치의 전사벨트 텐션 자동 인가 장치
WO2005018635A2 (en) 2003-08-07 2005-03-03 Cardiome Pharma Corp. Ion channel modulating activity i
WO2005079861A2 (en) * 2004-02-13 2005-09-01 Safeway Investments Ltd. Polymeric water soluble prodrugs
US7705036B2 (en) * 2004-04-01 2010-04-27 Cardiome Pharma Corp. Deuterated aminocyclohexyl ether compounds and processes for preparing same
CA2561819A1 (en) * 2004-04-01 2005-12-01 Cardiome Pharma Corp. Prodrugs of ion channel modulating compounds and uses thereof
CA2561733A1 (en) * 2004-04-01 2005-10-13 Cardiome Pharma Corp. Pegylated ion channel modulating compounds
WO2005097203A2 (en) * 2004-04-01 2005-10-20 Cardiome Pharma Corp. Serum protein conjugates of ion channel modulating compounds and uses thereof
JP5159616B2 (ja) * 2005-06-15 2013-03-06 カーディオム ファーマ コーポレイション アミノシクロヘキシルエーテル化合物の調製のための合成プロセス
US7845611B1 (en) * 2007-11-16 2010-12-07 Sholander Alfred M Door operated page turner device, system and method for books

Similar Documents

Publication Publication Date Title
JP5632910B2 (ja) C型肝炎ウイルス阻害剤
EP4121421A1 (en) Biaryl derivatives as yap/taz-tead protein-protein interaction inhibitors
RU2399620C2 (ru) Производные хинуклидина и их применение в качестве антагонистов мускариновых рецепторов м3
AU2015220560B2 (en) Pyrazolo[1,5-a]pyrimidine-5,7-diamine compounds as CDK inhibitors and their therapeutic use
KR102013512B1 (ko) 신규 3-인돌 치환 유도체, 제약 조성물 및 사용 방법
EP4479387A1 (en) Inhibitors of parg
JP2002509908A5 (cg-RX-API-DMAC7.html)
JP2025118740A (ja) 治療用化合物
RU2000127720A (ru) Аминоциклогексилово-эфирные соединения и их применение
CA2326777A1 (en) Aminocyclohexyl ether compounds and uses thereof
JP2023531709A5 (cg-RX-API-DMAC7.html)
JP2023533203A5 (cg-RX-API-DMAC7.html)
RU2005107314A (ru) Пиримидопроизводные, характеризующиеся антипролиферативной активностью
JP2015516420A5 (cg-RX-API-DMAC7.html)
RU2010154172A (ru) Соединения для лечения рака
RU2004104625A (ru) Аналоги простагландинов в качестве агонистов рецептора ep4
HRP20140687T1 (hr) Derivati benzofurana
JP2021525278A5 (cg-RX-API-DMAC7.html)
JP2007531731A5 (cg-RX-API-DMAC7.html)
TNSN07361A1 (en) 3,4-substituted pyrrolidine derivatives for the treatment of hypertension
RU2009120229A (ru) Производные хинуклидинола в качестве антагонистов мускариновых рецепторов
JP2010513434A5 (cg-RX-API-DMAC7.html)
JP2008539267A5 (cg-RX-API-DMAC7.html)
JP2020511547A5 (cg-RX-API-DMAC7.html)
JPWO2018216640A1 (ja) Ep4アンタゴニスト